http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-190846-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e5edd48190cba3fa70dd3975efd9831 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-91 |
| filingDate | 1983-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd27df79e37544e90436138dd3949281 |
| publicationDate | 1986-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-190846-B |
| titleOfInvention | Process for the production derivatives of pyrimidinones and of their acid addition salts |
| abstract | The invention relates to a process for the preparation of pyrimidinones for use as medicaments. The aim of the invention is the provision of compounds with antihypertensive, antiarrhythmic and beta-receptor blocking action. According to the invention, pyrimidinones of general formula I are prepared in which, for example: A and B, together with the two intervening carbon atoms, represent an optionally substituted phenyl ring or a pyridine ring, D an alkylene-o. Hydroxyalkylene group, R deep 3 u. R deep 5 each a hydrogen atom o. An alkyl group, R deep 4 is a hydrogen atom o. An alkoxy group u. R 6 is an alkyl group, an alkylene or hydroxyalkylene group which is terminally substituted by an optionally substituted phenyl or phenoxy group, and salts thereof. |
| priorityDate | 1982-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.